MedTrace Logo

Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men

NCT00919997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2015-10-05

No results posted yet for this study

Summary

RATIONALE: Gathering information about human papilloma virus (HPV) infection in HIV-positive men who have sex with men may help doctors learn more about the disease.

PURPOSE: This clinical trial is studying HPV infection in HIV-positive Indian men who have sex with men.

Conditions

  • Nonneoplastic Condition
  • Precancerous Condition

Interventions

GENETIC

DNA analysis

Anal pap smear, penile pap smear, blood collection, and saliva collection at a single study visit for HPV DNA analysis.

GENETIC

polymerase chain reaction

Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.

OTHER

fluorescence activated cell sorting

Blood and saliva samples collected at a single study visit will be analyzed for for HPV DNA.

OTHER

questionnaire administration

Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.

OTHER

study of socioeconomic and demographic variables

Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.

PROCEDURE

study of high risk factors

Describe risk factors for penile, anal and oral HPV infection in Indian HIV-seropositive MSM.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Joel Palefsky, MD · University of California, San Francisco

  • Dilip Mathai, MD · Christian Medical College and Hospital

  • Ashok Row Kavi · Humsafar Trust

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00919997 on ClinicalTrials.gov